Thus, our group observed that activation of AMPK by FLCN loss leads to upregulation of PGC1α and, consequently, elevated mitochondrial biogenesis and oxidative phosphorylation in cancer cells (Yan et al., 2014). This evidence concerns the gene FLCN and cancer.